<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>There have been several attempts to improve treatment and outcome of patients with primary mediastinal B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (PMBL) and Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>In recent years, chemotherapy dose intensification and the addition of rituximab have led to a remarkable progress and have developed into integral parts of treatment for both entities of <z:hpo ids='HP_0002665'>lymphoma</z:hpo> [1â€“4] </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we report our monocenter results of a high-dose <z:chebi fb="0" ids="44185">methotrexate</z:chebi> based alternating regimen with rituximab (<z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>/NHL 2002 protocol) in 15 patients with PMBL and 28 patients with <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Since the early 1980s, protocols of GMALL have been continuously adapted and in the meantime they have become reference treatment for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> and <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> in Germany </plain></SENT>
<SENT sid="4" pm="."><plain>The latest changes comprised the additional use of rituximab, standardized G-CSF support,implementation of high-dose <z:chebi fb="0" ids="28680">cytarabine</z:chebi>, intrathecal triple therapy,and age-adjusted stratification </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, we additionally amended supportive care with palifermin as it reduced severity and prevalence of mucositis [5] </plain></SENT>
</text></document>